Literature DB >> 34261746

Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.

Guendalina Beatrice Bonifacio1, Dharmini Patel2, Sarah Cook2, Elena Purcaru2,3, Michael Couzins2,4, Janine Domjan2,4, Suzanne Ryan2, Ahmad Alareed4, Orla Tuohy2,4, Sean Slaght2,4, Julian Furby2,5, David Allen2, Haider A Katifi2, Lucy Kinton2.   

Abstract

Entities:  

Keywords:  Guillain-Barre syndrome; neuropathy

Mesh：

Substances：

Year:  2021        PMID： 34261746     DOI： 10.1136/jnnp-2021-327027

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  16 in total

1.  Guillain-Barré syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance study.

Authors:  Arina A Tamborska; Bhagteshwar Singh; Sonja E Leonhard; Eva Maria Hodel; Julia Stowe; Taylor Watson-Fargie; Peter M Fernandes; Andreas C Themistocleous; Jacob Roelofs; Kathryn Brennan; Caroline Morrice; Benedict D Michael; Bart C Jacobs; Helen McDonald; Tom Solomon
Journal:  BMJ Neurol Open       Date:  2022-07-12

Review 2.  COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review.

Authors:  Naim Mahroum; Noy Lavine; Aviran Ohayon; Ravend Seida; Abdulkarim Alwani; Mahmoud Alrais; Magdi Zoubi; Nicola Luigi Bragazzi
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

3.  Bilateral facial palsy with paresthesias, variant of Guillain-Barré syndrome following COVID-19 vaccine: A case series of 9 patients.

Authors:  J I Castiglione; J M Crespo; L Lecchini; F O Silveira; M B Luis; N Cotti; C J Simison; F Aguirre; M A Piedrabuena; R N Alonso; C L Azcona; P S Sosa; E Maldonado; F Barroso
Journal:  Neuromuscul Disord       Date:  2022-05-11       Impact factor: 3.538

4.  Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform.

Authors:  Jemma L Walker; Anna Schultze; John Tazare; Arina Tamborska; Bhagteshwar Singh; Katherine Donegan; Julia Stowe; Caroline E Morton; William J Hulme; Helen J Curtis; Elizabeth J Williamson; Amir Mehrkar; Rosalind M Eggo; Christopher T Rentsch; Rohini Mathur; Sebastian Bacon; Alex J Walker; Simon Davy; David Evans; Peter Inglesby; George Hickman; Brian MacKenna; Laurie Tomlinson; Amelia Ca Green; Louis Fisher; Jonathan Cockburn; John Parry; Frank Hester; Sam Harper; Christopher Bates; Stephen Jw Evans; Tom Solomon; Nick J Andrews; Ian J Douglas; Ben Goldacre; Liam Smeeth; Helen I McDonald
Journal:  Vaccine       Date:  2022-06-07       Impact factor: 4.169

Review 5.  COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era.

Authors:  Arens Taga; Giuseppe Lauria
Journal:  J Peripher Nerv Syst       Date:  2022-03-14       Impact factor: 5.188

6.  Chronic Inflammatory Demyelinating Polyneuropathy after ChAdOx1 nCoV-19 Vaccination.

Authors:  Caterina Francesca Bagella; Davide G Corda; Pietro Zara; Antonio Emanuele Elia; Elisa Ruiu; Elia Sechi; Paolo Solla
Journal:  Vaccines (Basel)       Date:  2021-12-19

7.  Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.

Authors:  Yew Li Dang; Alexander Bryson
Journal:  BMJ Case Rep       Date:  2021-11-30

8.  Guillain-Barré Syndrome and Variants Following COVID-19 Vaccination: Report of 13 Cases.

Authors:  Jee-Eun Kim; Young Gi Min; Je-Young Shin; Young Nam Kwon; Jong Seok Bae; Jung-Joon Sung; Yoon-Ho Hong
Journal:  Front Neurol       Date:  2022-01-27       Impact factor: 4.003

9.  Vaccine hesitancy with a history of Guillain Barre Syndrome: Weighing the risks and benefits of SARS-CoV-2 vaccination.

Authors:  Aleksandra Murawska Baptista; Akankcha Alok; Claudia Libertin
Journal:  IDCases       Date:  2022-03-05

10.  Neuromuscular complications after COVID-19 vaccination: a series of eight patients.

Authors:  Wouter Leemans; Sofie Antonis; Wouter De Vooght; Robin Lemmens; Philip Van Damme
Journal:  Acta Neurol Belg       Date:  2022-05-02       Impact factor: 2.471
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.